0001582949-16-000001.txt : 20160418 0001582949-16-000001.hdr.sgml : 20160418 20160418160336 ACCESSION NUMBER: 0001582949-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20160418 DATE AS OF CHANGE: 20160418 EFFECTIVENESS DATE: 20160418 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rapamycin Holdings, Inc. CENTRAL INDEX KEY: 0001582949 IRS NUMBER: 364743691 STATE OF INCORPORATION: DE FISCAL YEAR END: 0912 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-261570 FILM NUMBER: 161576970 BUSINESS ADDRESS: STREET 1: 12500 NETWORK BLVD. SUITE #105 CITY: SAN ANTONIO STATE: TX ZIP: 78249 BUSINESS PHONE: 210-381-2486 MAIL ADDRESS: STREET 1: 12500 NETWORK BLVD. SUITE #105 CITY: SAN ANTONIO STATE: TX ZIP: 78249 D 1 primary_doc.xml X0707 D LIVE 0001582949 Rapamycin Holdings, Inc. 17319 San Pedro Bldg #2 Suite #208 SAN ANTONIO TX TEXAS 78232 210-381-2486 DELAWARE None None Corporation true 2012 Randy H Goldsmith 3802 Woodbrook Dr. Austin TX TEXAS 78759 Executive Officer Director President and Chief Executive Officer (and Board of Directors Member) Stephen Dufilho 3218 Seven Oaks Dr. San Antonio TX TEXAS 78217 Director Chairman of the Board of Directors Mark Horsey 722 Mesa Ridge San Antonio TX TEXAS 78258 Executive Officer Secretary and Chief Financial Officer Pharmaceuticals $1 - $1,000,000 06c false true false true false 100000 2000000 0 2000000 Offering Period began on March 9th 2016, and will close by August 31st 2016 unless extended by the Board of Directors false 0 0 0 N/A 200000 true The CEO and CFO are compensated by the Company. false Rapamycin Holdings, Inc. Mark Horsey Mark D. Horsey Secretary, Treasurer and Chief Financial Officer 2016-04-18